Cytosorbents (CTSO) Insider Trading & Ownership $1.01 +0.02 (+2.02%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$1.01 0.00 (-0.40%) As of 04/15/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cytosorbents (NASDAQ:CTSO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$29,313.07Number OfInsiders Selling(Last 12 Months)0 Get CTSO Insider Trade Alerts Want to know when executives and insiders are buying or selling Cytosorbents stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CTSO Insider Buying and Selling by Quarter Remove Ads Cytosorbents Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2024Peter J MarianiCFOBuy20,000$0.96$19,200.00 12/11/2024Peter J MarianiCFOBuy11,363$0.89$10,113.07 (Data available from 1/1/2013 forward) CTSO Insider Trading Activity - Frequently Asked Questions Who is on Cytosorbents's Insider Roster? The list of insiders at Cytosorbents includes Al Kraus, Alan D Sobel, Edward Raymond Jones, Jiny Kim, Kathleen P Bloch, Michael G Bator, Peter J Mariani, Phillip P Chan, and Vincent Capponi. Learn more on insiders at CTSO. What percentage of Cytosorbents stock is owned by insiders? 6.60% of Cytosorbents stock is owned by insiders. Learn more on CTSO's insider holdings. Which Cytosorbents insiders have been buying company stock? The following insiders have purchased CTSO shares in the last 24 months: Alan D Sobel ($30,000.81), Kathleen P Bloch ($40,505.00), Michael G Bator ($9,570.00), and Peter J Mariani ($29,313.07). How much insider buying is happening at Cytosorbents? Insiders have purchased a total of 70,220 CTSO shares in the last 24 months for a total of $109,388.88 bought. Cytosorbents Key ExecutivesDr. Phillip P. Chan M.D. (Age 54)Ph.D., CEO & Director Compensation: $651.78kMr. Vincent J. Capponi M.S. (Age 66)President & COO Compensation: $543.25kMs. Kathleen P. Bloch CPA (Age 69)M.B.A., Chief Financial Officer Compensation: $587.92kDr. Efthymios N. Deliargyris FACC (Age 55)FESC, FSCAI, M.D., Chief Medical Officer Compensation: $585.38kMs. Terri Anne Powers M.B.A.Vice President of Investor Relations & Corporate CommunicationsDr. Christian Steiner M.D.Executive Vice President of Sales & MarketingMr. Christopher Cramer M.B.A.M.S., Senior Vice President of Business DevelopmentJodi HooverExecutiveDr. Robert H. Bartlett M.D. (Age 85)Co-Chairman of Cardiac Surgery Advisory Board & Consultant Compensation: $54k More Insider Trading Tools from MarketBeat Related Companies SMTI Insider Buying NVRO Insider Buying RCEL Insider Buying INGN Insider Buying ELMD Insider Buying PDEX Insider Buying LNSR Insider Buying LAKE Insider Buying TLSI Insider Buying LUCD Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own Stock This page (NASDAQ:CTSO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.